WNK2 and cancer: Several possible molecular signaling pathways for the therapeutic application of CAPE in cancers including NFκB, p53, Wnt/β-catenin, PI3K/Akt, MAPK (mitogen-activated protein kinase), AMPK (AMP-activated kinase), and so forth have been discussed [3,6,7].